Takeshi Yamada, Miu Yagita, Yutaka Kobayashi, Goh Sennari, Hiroyuki Shimamura, Hidehito Matsui, Yuki Horimatsu, Hideaki Hanaki, Tomoyasu Hirose, Satoshi O̅mura, Toshiaki Sunazuka
Index: 10.1021/acs.joc.8b00045
Full Text: HTML
Total synthesis of bottromycin A2 can be accomplished through a diastereoselective Mannich reaction of a chiral sulfinamide, mercury-mediated intermolecular amidination, and cyclization of a constrained tetracyclic peptide. Exploitation of this process allowed the synthesis of several novel bottromycin analogs. The antimicrobial activity of these analogs was evaluated in vitro against Gram-positive bacteria, such as methicillin resistant Staphylococcus aureus (MRSA) and vancomycin resistant enterococci (VRE). Structure–activity relationships were explored taking into consideration the unique three-dimensional structure of the compounds. Notably, one of the new analogs devoid of a methyl ester, which is known to lower the in vivo efficacy of bottromycin, exhibited antibacterial bioactivity comparable to that of vancomycin.
Synthesis and Unique Optical Properties of Selenophenyl BODI...
2018-04-19 [10.1021/acs.joc.8b00782] |
Synthesis of 3,5-Disubstituted BODIPYs Bearing N-Containing ...
2018-04-17 [10.1021/acs.joc.8b00087] |
Steric Hindrance Underestimated: It is a Long, Long Way to T...
2018-04-17 [10.1021/acs.joc.8b00496] |
Stereoselective Sequential [4+2]/[2+2] Cycloadditions Involv...
2018-04-16 [10.1021/acs.joc.8b00346] |
Pd-Induced Double C–H Bond Activation in Annulative Synthese...
2018-04-16 [10.1021/acs.joc.8b00630] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved